Overview Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069 Status: Completed Trial end date: 2014-06-01 Target enrollment: Participant gender: Summary Study to investigate safety, tolerability and effect of multiple dosing with AZD 4721 and/or with AZD 5069 Phase: Phase 1 Details Lead Sponsor: AstraZeneca